收回:LncRNA Hotair在非小细胞肺癌中的表型变化及其临床应用
Journal of healthcare engineering
|August 11, 2023
概括
这篇文章已被撤回. 最初的研究,DOI 10.1155/2021/3215143 标识,不再被认为是有效的科学文献.
科学领域:
- 撤销通知 撤销通知
背景情况:
- 标识DOI 10.1155/2021/3215143的物品可以收回.
研究的目的:
- 正式宣布撤回指定的物品.
主要方法:
- 一个撤回通知已经发出.
主要成果:
- 文章已正式撤回,不应引用.
结论:
- 科学记录已经更新,以反映这一撤回.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


